Lower Extremity Realignment Therapy for the Treatment of Medial Knee Osteoarthritis- A Pilot Study
IRB Number: 28008
inactiveAugust 02, 2011
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
- Howard J. Hillstrom, PhD
Co-Investigators
- Sherry Backus, PT, DPT, MA
- Eric Bogner, MD
- Frank A. Cordasco, MD, MS
- Jocelyn Hafer, MA
- Glenn Garrison, CPO
- David Hunter, MD, PhD
- Yatin Kirane, D.Orth, PhD
- Andrew Kraszewski, MS
- Mark Lenhoff, BS
- Stephen Lyman, PhD
- Lisa A. Mandl, MD, MPH
- Helene Pavlov, MD, FACR
- Hollis G. Potter, MD
- Scott A. Rodeo, MD
- Peter Torzilli, PhD
- Thomas L Wickiewicz, MD
- Riley J. Williams, MD
Summary
Inclusion/Exclusion Criteria
Inclusion Criteria:
• Men and women between the ages of 40 and 80 years
• Mild to moderate knee OA
• Ability to walk independently without an assistive device
Exclusion Criteria:
• Pregnant or nursing women
• Advanced OA in other knee
• History of replacement surgery of any lower limb joint
• Neuro-musculo-skeletal condition that interferes with walking gait (e.g. rheumatoid arthritis, psoriasis, gout, joint infection, venous or lymphatic leg stasis, peripheral vascular disease, etc.)
• Significantly compromised cardiovascular condition
• Currently taking anticoagulants and narcotic analgesics
7. Contact Information for the study:
Contact Information
Howard J. Hillstrom, Ph.D.
212.606.1507
HillstromH@HSS.edu